11C-PiB

DRUG6 trials

Sponsors

Avid Radiopharmaceuticals, Oriental Neurosurgery Evidence-Based-Study Team, José A. Luchsinger, National Institute of Mental Health (NIMH), University of Colorado, Denver

Conditions

Alzheimer DiseaseAlzheimer's DiseaseAtherosclerosisCognitive ImpairmentDementiaHealthy AgingParkinson DiseaseVascular Diseases

Early Phase 1

Brain Imaging in the Diabetes Prevention Program Outcomes Study

TerminatedNCT03757910

José A. LuchsingerAlzheimer Disease

Start: 2019-10-01End: 2023-01-31Updated: 2024-03-04

Phase 1

Florbetapir Calibration to the Centiloid Scale

CompletedNCT02120664

Avid RadiopharmaceuticalsAlzheimer's Disease

Start: 2014-04-30End: 2015-09-30Updated: 2017-03-09

PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand

TerminatedNCT03958630

National Institute of Mental Health (NIMH)Dementia

Start: 2019-07-03End: 2023-12-04Updated: 2024-05-01

Phase 2

11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes

Oriental Neurosurgery Evidence-Based-Study TeamParkinson Disease

Start: 2017-07-12End: 2021-10-12Target: 200Updated: 2018-06-13

Unknown Phase

11C-PIB PET Study in MESA at Columbia University

CompletedNCT03981380

José A. LuchsingerAlzheimer Disease, Atherosclerosis, Cognitive Impairment +1

Start: 2020-08-01End: 2024-02-05Updated: 2025-02-18

Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment

TerminatedNCT04505735

University of Colorado, DenverAlzheimer Disease, Healthy Aging

Start: 2016-11-22End: 2022-09-23Updated: 2023-04-07